Keyword

orteronel

Description: Orteronel is an investigational anticancer drug that inhibits the CYP17 enzyme, reducing androgen production in prostate and other hormone-sensitive cancers.
Wikidata ID: wiki/Q6581305
OpenAlex ID: keywords/orteronel
2011 · Christophe Massard, Karim Fizazi · Clinical Cancer Research · 190
2013 · Lina Yin, Qingzhong Hu · Nature Reviews Urology · 183
2015 · Lissette Gomez, Jason R. Kovac, et al. · Steroids · 90
2016 · Anitha B. Alex, Sumanta K. Pal, et al. · Therapeutic Advances in Medical Oncology · 67
2012 · Michael T. Schweizer, Emmanuel S. Antonarakis · Therapeutic Advances in Urology · 67
2017 · John D. Norris, Stephanie J. Ellison, et al. · Journal of Clinical Investigation · 57
2017 · Elyse M. Petrunak, Steven A. Rogers, et al. · Drug Metabolism and Disposition · 51
2019 · F. Peter Guengerich, Clayton J. Wilkey, et al. · Journal of Biological Chemistry · 49
2022 · Neeraj Agarwal, Catherine M. Tangen, et al. · Journal of Clinical Oncology · 47
2016 · Ian M. Bird, David H. Abbott · The Journal of Steroid Biochemistry and Molecular Biology · 47
2016 · Sameer S. Udhane, Bernhard Dick, et al. · Biochemical and Biophysical Research Communications · 46
2012 · Takahito Hara, Jin Kouno, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 34
Works count: 183
Citation count: 2,450
Year
Topic
Type